Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.

Shijin YuanYan XiaLihong ShenLiuqing YeLisha LiLifen ChenXinyou XieHaizhou LouJun Zhang

Published in: Cancer immunology, immunotherapy : CII (2020)

We developed predictive nomograms based on easily available factors to help clinicians early assess response and prognosis for NSCLC patients received anti-PD-1 antibody.

Keyphrases

ejection fraction
small cell lung cancer
prognostic factors
epidermal growth factor receptor